Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) shares were down 2.4% on Tuesday . The company traded as low as C$4.79 and last traded at C$4.84. Approximately 69,983 shares changed hands during mid-day trading, an increase of 46% from the average daily volume of 47,993 shares. The stock had previously closed at C$4.96.
Medexus Pharmaceuticals Stock Performance
The company’s 50-day moving average price is C$4.48 and its 200-day moving average price is C$3.72. The firm has a market capitalization of C$154.50 million, a PE ratio of -69.71 and a beta of 0.22.
About Medexus Pharmaceuticals
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Recommended Stories
- Five stocks we like better than Medexus Pharmaceuticals
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
